Toggle Offcanvas
...
 
Bevacizumab Tenders

Bevacizumab Tenders

View Bevacizumab tenders, RFPs and contracts. Bid on readily available Bevacizumab tenders with the best and most comprehensive tendering platform, since 2002.
Bevacizumab is a drug used in cancer treatment that stops tumors from growing new blood vessels. It helps slow down the spread of cancer and is also used for certain eye diseases to prevent vision loss.

Bidding for Bevacizumab tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Bevacizumab.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Bevacizumab market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Bevacizumab tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

23 Live Notices for Bevacizumab Tenders

Showing 1 to 20

Purchase And Successive Delivery Of Medicinal Products To Drug Programs, Chemotherapy And Rdtl
country Poland
posting date25 Aug 2025
deadline03 Oct 2025
Object: Electronic Auction - Price Registration Training For The Eventual Supply Of Injectable Cancer Drugs To Meet The Needs Of The Pmpe/Cbmp Hospital Medical Center, According To The Conditions, Specifications, Quantities And Requirements Contained In The Term Of Reference.
country Brazil
posting date15 Aug 2025
deadline29 Aug 2025
Object: Electronic Auction - Acquisition Of Medicines - Exclusive Production. (Process: 25410.011318/2024-09)
country Brazil
posting date15 Aug 2025
deadline29 Aug 2025
Object: Electronic Auction - Registration Of Drug Prices, In Compliance With Court Orders.
country Brazil
posting date13 Aug 2025
deadline27 Aug 2025
Market Survey For The Set -Up And Delivery Of Siringi Siring Syodes Of Bevacizumab For Intravitreal Use Necessary For Asst Bergamo Ovest.
country Italy
posting date11 Aug 2025
deadline03 Sep 2025
Delivery Of Oncological Drugs For The Needs Of Cozl.
country Poland
posting date08 Aug 2025
deadline12 Sep 2025
Supply Oncological Drugs In The National Program D Oncology
country Romania
posting date04 Aug 2025
deadline27 Aug 2025
Supply Oncological Drugs In The National Program D Oncology
country Romania
posting date24 Jul 2025
deadline27 Aug 2025
Supply Oncological Drugs In The National Program D Oncology
country Romania
posting date23 Jul 2025
deadline27 Aug 2025
Request For International Offers To Purchase Hospital Medicines For The Year 2026-2027 (I/2027-2026)
country Tunisia
posting date12 Jul 2025
deadline26 Aug 2025
Pharmaceutical Discount Contracts In Accordance With Section 130A (8C) Sgb V From 01.08.2025 On Various Active Substances In The Context Of An Open House Process
country Germany
posting date27 May 2025
deadline21 May 2027
Pharmaceutical Discount Contracts In Accordance With Section 130A (8C) Sgb V From 01.08.2025 On Various Active Substances In The Context Of An Open House Process
country Germany
posting date27 May 2025
deadline21 May 2027
Open-House Drug Discount Contracts In Accordance With Section 130A (8C) Sgb V Bevacizumab, Atc L01Fg01-Contract Regions Of Lower Saxony, Bremen And Saxony-Anhalt
country Germany
posting date29 Apr 2025
deadline21 Apr 2027
Open-House Drug Discount Contracts In Accordance With Section 130A (8C) Sgb V Bevacizumab, Atc L01Fg01-Contract Regions Of Lower Saxony, Bremen And Saxony-Anhalt
country Germany
posting date29 Apr 2025
deadline21 Apr 2027
Open House Pharmaceutical Discount Contracts In Accordance With Section 130A (8C) Sgb V Bevacizumab, Atc L01Fg01
country Germany
posting date16 Apr 2025
deadline16 Apr 2027
Open-House Drug Discount Contracts In Accordance With Section 130A (8C) Sgb V For The Kv-Region Berlin
country Germany
posting date07 Mar 2025
deadline21 Feb 2026
Open-House Drug Discount Contracts In Accordance With Section 130A (8C) Sgb V For The Kv Region Mecklenburg-Western Pomerania
country Germany
posting date06 Mar 2025
deadline21 Feb 2026
Open-House Drug Discount Contracts In Accordance With Section 130A (8C) Sgb V For The Kv Region Brandenburg
country Germany
posting date06 Mar 2025
deadline21 Feb 2026
Environmentally Friendly Supply Of Biological Human Medicines With Biosimilars For Public Health Centres In Valencia
country Spain
posting date30 Dec 2024
deadline01 Oct 2025
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Bevacizumab
country Germany
posting date22 May 2024
deadline10 May 2026

Share Share this page